Hyundai Cancer Institute :: Meet the Histiocytosis Treatment Program Team
The Histiocytosis Treatment Program at the Cancer Institute is a multidisciplinary team of nationally recognized medical experts who treat pediatric patients with hystiocytosis.
The Histiocytosis Treatment Program is led by Elyssa Rubin, M.D. and Lilibeth Torno, M.D. Dr. Rubin is board-certified in pediatrics and pediatric hematology/oncology. She completed her fellowship in pediatric hematology/oncology at Children’s Hospital of Orange County and did her pediatric internship and residency training at Kaiser Permanente Los Angeles Medical Center. Dr. Rubin attended medical school at the Sackler School of Medicine, NY State/American Branch in Tel Aviv, Israel.
Dr. Lilibeth Torno is board-certified in pediatrics and pediatric hematology and oncology. Dr. Torno completed her fellowship training at Children’s Hospital of Los Angeles. She completed her residency at CHOC. She attended medical school at University of Santo Tomas, Manila, Philippines. Dr. Torno also speaks Filipino.
Together, Dr. Rubin and Dr. Torno have presented internationally on histiocytosis and treat a significant number of the region’s histiocytosis patients.
|Associate Spotlight: Megan El-Hin-Oncology Nurse
Megan Megan El-Hin was destined to be an oncology nurse. In fact, you might say that it is in her blood. Following in the footsteps of her mother who has been an oncology nurse for more than 30 years, Megan became an oncology nurse at the Hyundai Cancer Institute at CHOC Children's in 2006.
Read more about Megan...